With the inception of Rivaroxaban, there are surely more hopes for an effectual medication to treat Atrial Fibrillation. While there are not many heart medications other than Coumadin, this oral medication is being welcomed by one and all. Infact, National Blood Clot Alliance (NBCA) is also pleased and is looking forward for the response of the people.
The abnormal rhythm of the heartbeat is Atrial Fibrillation where the two upper chambers of the heart contract and start beating. This irregular heartbeat can make one prone to severe problems without undergoing treatment. One must immediately opt for some sort of medication to take care of the same.
Like every other anticoagulant, Rivaroxaben is also known to cause this adverse effect of making one prone to bleeding. However the other good aspect that we have to consider is that one has less chances of being susceptible to bleeding in the brain as compared to the other medications like Coumadin. This can surely gain this medication the inclination from the consumer’s side.
With around 2.6 million people in USA alone are reported to be suffering from AFib, we surely need a skilled medication to treat the same as soon as possible. Besides, this rate is going to rise higher is what the health experts say. Around 2050, there might be around 12 million people suffering from the same which is many times higher. In the last two years, Rivoroxaben remains the second anticoagulant to be accepted and approved by the FDA (Food And Drug Administration).
Besides there is still loads of studies and researches that are being carried out for blood thinners that can treat these blood clot problems in one’s leg and lungs.
The abnormal rhythm of the heartbeat is Atrial Fibrillation where the two upper chambers of the heart contract and start beating. This irregular heartbeat can make one prone to severe problems without undergoing treatment. One must immediately opt for some sort of medication to take care of the same.
Like every other anticoagulant, Rivaroxaben is also known to cause this adverse effect of making one prone to bleeding. However the other good aspect that we have to consider is that one has less chances of being susceptible to bleeding in the brain as compared to the other medications like Coumadin. This can surely gain this medication the inclination from the consumer’s side.
With around 2.6 million people in USA alone are reported to be suffering from AFib, we surely need a skilled medication to treat the same as soon as possible. Besides, this rate is going to rise higher is what the health experts say. Around 2050, there might be around 12 million people suffering from the same which is many times higher. In the last two years, Rivoroxaben remains the second anticoagulant to be accepted and approved by the FDA (Food And Drug Administration).
Besides there is still loads of studies and researches that are being carried out for blood thinners that can treat these blood clot problems in one’s leg and lungs.
